Skip to main content
Hodgkin-directed therapy may benefit patients with rare CLL subtype
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Hodgkin-directed therapy may benefit patients with rare CLL subtype
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Mustard Vesicant
0
0.9
Toxicology
0
0.36
Lymphoma
0
0.33
Antineoplastic Drug
0
0.14
Clinical Guidelines
0
0.14
Hodgkin Lymphoma
0
0.99
Biologic Therapy
0
0.08
Biopsy
0
0.08
Blood
0
0.08
Cancer
0
0.08
Corticosteroids
0
0.08
Epstein-Barr Virus
0
0.08
Monoclonal Antibody
0
0.08
Radiation Therapy
0
0.08
T-Lymphocyte
0
0.08
Tissue
0
0.08
Specialty
Lead
score
Hematology-Oncology
1
1
Edit Tags